- 全部删除
- 您的购物车当前为空
Lucerastat(NBDGJ,芦舍司他)是一种口服的葡萄糖神经酰胺合酶(Glucosylceramide Synthase, GCS)的抑制剂,具有治疗法布里病的潜力。 GCS是鞘糖脂合成的关键酶,抑制其活性可减少有害底物的积累。
Lucerastat(NBDGJ,芦舍司他)是一种口服的葡萄糖神经酰胺合酶(Glucosylceramide Synthase, GCS)的抑制剂,具有治疗法布里病的潜力。 GCS是鞘糖脂合成的关键酶,抑制其活性可减少有害底物的积累。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 4,399 | In stock |
Lucerastat 相关产品
产品描述 | Lucerastat(NBDGJ) is an orally available inhibitor of Glucosylceramide Synthase (GCS) with therapeutic potential for Fabry disease. GCS is a key enzyme in sphingolipid synthesis and inhibition of its activity reduces the accumulation of harmful substrates. |
别名 | 芦舍司他, OGT 923, NBDGJ, NB DGJ, N-(n-Butyl)deoxygalactonojirimycin, ACT 434964 |
分子量 | 219.28 |
分子式 | C10H21NO4 |
CAS No. | 141206-42-0 |
Smiles | C(CCC)N1[C@H](CO)[C@H](O)[C@H](O)[C@@H](O)C1 |
密度 | 1.234 g/cm3 (Predicted) |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 20 mg/mL (91.21 mM), Sonication is recommended. H2O: 20 mg/mL (91.21 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO/H2O
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容